MedTrace Logo

Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide

NCT00202657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2011-12-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether patients with Parkinson's disease and treated with pergolide have a higher risk of heart valve disease compared to patients with Parkinson's disease not treated with pergolide.

Conditions

Interventions

PROCEDURE

echocardiography

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Société Française de Cardiologie

    lead OTHER

Principal Investigators

  • Jean-Christophe CORVOL, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2007-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00202657 on ClinicalTrials.gov